Eledon Pharmaceuticals
ELDN
ELDN
48 hedge funds and large institutions have $29.7M invested in Eledon Pharmaceuticals in 2016 Q2 according to their latest regulatory filings, with 6 funds opening new positions, 17 increasing their positions, 16 reducing their positions, and 7 closing their positions.
New
Increased
Maintained
Reduced
Closed
Holders
48
Holders Change
-1
Holders Change %
-2.04%
% of All Funds
1.28%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
6
Increased
17
Reduced
16
Closed
7
Calls
$55K
Puts
–
Net Calls
+$55K
Net Calls Change
+$55K
Top Buyers
1 |
PA
Perceptive Advisors
New York
|
+$968K |
2 |
BCM
Bridgeway Capital Management
Houston,
Texas
|
+$221K |
3 |
PAM
Paradigm Asset Management
New York
|
+$97K |
4 |
CS
Credit Suisse
Zurich,
Switzerland
|
+$72K |
5 |
Ameriprise
Minneapolis,
Minnesota
|
+$59.7K |
Top Sellers
1 |
NHAS
Novo Holdings A/S
Hellerup,
Denmark
|
-$1.89M |
2 |
SAM
Senzar Asset Management
New York
|
-$695K |
3 |
SM
Sabby Management
Miami Beach,
Florida
|
-$347K |
4 |
Bank of America
Charlotte,
North Carolina
|
-$166K |
5 |
AA
ALPS Advisors
Denver,
Colorado
|
-$142K |